Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease

BackgroundInflammatory cytokines have been considered to be significant factors contributing to the development and progression of non-alcoholic fatty liver disease (NAFLD). However, the role of inflammatory cytokines in NAFLD remains inconclusive.ObjectiveThis study aimed to evaluate the associatio...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Frontiers in Immunology
المؤلفون الرئيسيون:	Yamei Duan, Xiongfeng Pan, Jiayou Luo, Xiang Xiao, Jingya Li, Prince L. Bestman, Miyang Luo
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2022-05-01
الموضوعات:	inflammatory cytokines non-alcoholic fatty liver disease non-alcoholic steatohepatitis hepatic steatosis hepatic fibrosis
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.880298/full

مواد مشابهة

Effectiveness and Safety of Resmetirom in the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
حسب: Dipan Saha, وآخرون
منشور في: (2025-10-01)

Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review
حسب: Huanqiu Wang, وآخرون
منشور في: (2022-08-01)

Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease
حسب: Youwen Tan, وآخرون
منشور في: (2024-12-01)

NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
منشور في: (2012-04-01)

SMYD2 inhibitors have no effect in improving non-alcoholic steatohepatitis in mice
حسب: Lanzexin Yang, وآخرون
منشور في: (2025-06-01)

Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis
حسب: Svintsitskyy A., وآخرون
منشور في: (2016-07-01)

The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
حسب: Abdulrahman Ismaiel, وآخرون
منشور في: (2021-12-01)

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
حسب: Ma Ai Thanda Han
منشور في: (2020-09-01)

Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease
حسب: V.N. dos Santos, وآخرون
منشور في: (2005-05-01)

A CLINICAL CASE OF DRUG HEPATITIS A WOMAN WHO IS PREGNANT WITH OBESITY
حسب: I. O. Makarov, وآخرون
منشور في: (2016-05-01)

Single-cell transcriptomics of hepatic stellate cells uncover crucial pathways and key regulators involved in non-alcoholic steatohepatitis
حسب: Weiwei He, وآخرون
منشور في: (2023-01-01)

Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients
حسب: Yan Huang, وآخرون
منشور في: (2022-01-01)

Non-alcoholic fatty liver disease: Definition and subtypes
حسب: Seul Ki Han, وآخرون
منشور في: (2023-02-01)

SENSITIVITY AND SPECIFICITY OF VECTORCARDIOGRAPHY IN DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION COMORBID WITH LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS
حسب: I. E. Belaya, وآخرون
منشور في: (2015-12-01)

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
حسب: Seul Ki Han, وآخرون
منشور في: (2023-07-01)

β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
حسب: Janet Sánchez-Quevedo, وآخرون
منشور في: (2022-09-01)

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease
حسب: N. V. Bivalkevich, وآخرون
منشور في: (2015-09-01)

Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease
حسب: Carlo Smirne, وآخرون
منشور في: (2020-11-01)

The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials
حسب: Ioana-Cristina Bica, وآخرون
منشور في: (2023-06-01)

Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease
حسب: Kalliopi Zachou, وآخرون
منشور في: (2023-08-01)

Esteatosis hepática metabólica y nefropatía diabética: una llamada a la acción
حسب: Salvador Benlloch, وآخرون
منشور في: (2024-03-01)

The relationship between diabetes mellitus and non-alcoholic fatty liver disease: a clinical and instrumental paired study
حسب: Armida N. Sasunova, وآخرون
منشور في: (2024-09-01)

Platelets in Non-alcoholic Fatty Liver Disease
حسب: Andrea Dalbeni, وآخرون
منشور في: (2022-02-01)

The ultrasound‐guided attenuation parameter is useful in quantification of hepatic steatosis in non‐alcoholic fatty liver disease
حسب: Yu Ogino, وآخرون
منشور في: (2021-08-01)

Inhibition of MAP4K4 signaling initiates metabolic reprogramming to protect hepatocytes from lipotoxic damage
حسب: Sumit Kumar Anand, وآخرون
منشور في: (2022-07-01)

Impact of pre-operative weight loss on non-alcoholic fatty liver disease histopathology and insulin resistance in individuals undergoing bariatric surgery: a propensity matched cross-sectional comparison
حسب: Fábio Henrique Ribeiro Maldonado, وآخرون
منشور في: (2023-06-01)

Ultrasound-Based Hepatic Elastography in Non-Alcoholic Fatty Liver Disease: Focus on Patients with Type 2 Diabetes
حسب: Georgiana-Diana Cazac, وآخرون
منشور في: (2022-09-01)

Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
حسب: Hyeok-Hee Lee, وآخرون
منشور في: (2020-06-01)

Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis
حسب: Nancy Magee, وآخرون
منشور في: (2022-12-01)

Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease
حسب: Hye Kyung Hyun, وآخرون
منشور في: (2024-03-01)

Clinical usefulness of serum ferritin level in patients with fatty liver
حسب: Norhan Ali, وآخرون
منشور في: (2020-04-01)

Alcoholic liver disease: State-of-the-art
حسب: I V Maev, وآخرون
منشور في: (2014-04-01)

Adherence to plant based diets reduce the risk of hepatic fibrosis in nonalcoholic fatty liver disease
حسب: Mahsa Miryan, وآخرون
منشور في: (2025-05-01)

Non-Invasive Serum Markers of Non-Alcoholic Fatty Liver Disease Fibrosis: Potential Tools for Detecting Patients with Cardiovascular Disease
حسب: Ling-Zi Chen, وآخرون
منشور في: (2024-09-01)

Biochemical and histological changes in two nonalcoholic fatty liver disease models of different severity
حسب: T. V. Brus, وآخرون
منشور في: (2024-07-01)

Lipid metabolism in patients with chronic hepatitis C, non-alcoholic fatty liver disease and obesity under the influence of treatment
حسب: M.A. Derbak, وآخرون
منشور في: (2024-04-01)

Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
حسب: Sandra Steensels, وآخرون
منشور في: (2020-07-01)

Combination of autoimmune hepatitis to non-alcoholic steatohepatitis (Clinical case)
حسب: A. A. Driga, وآخرون
منشور في: (2010-11-01)

The effect of probiotic supplementation on non-alcoholic fatty liver disease (NAFLD) fibrosis score in patients attending a tertiary hospital clinic in Cairo, Egypt
حسب: Alaa Ahmed Abd El Hamid, وآخرون
منشور في: (2024-10-01)

Correlation between CT Abdominal Anthropometric Measurements and Liver Density in Individuals with Non-Alcoholic Fatty Liver Disease
حسب: Dragoș Constantin Cucoranu, وآخرون
منشور في: (2023-03-01)